STOCK TITAN

Prospect Capital Financials

PSEC
FY2025 annual
Revenue $12.3M -55.4% YoY
Net Income -$490.5M -309.5% YoY
EPS (Diluted) -$1.35 YoY not available
Free Cash Flow Not reported for FY2025
Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE June

Prospect Capital (PSEC) reported $12.3M in revenue for fiscal year 2025, down 55.4% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI PSEC FY2025

A shrinking balance sheet is funding cash distributions, while reported earnings swing far more than cash generation.

FY2025 showed negative earnings but positive cash release: net income was -$490.5M even as operating cash flow reached $523.2M. Because assets also fell by roughly 13.4% from FY2024 and financing cash flow was -$558.3M, the cleaner reading is balance-sheet contraction rather than a business that simply turned accounting profit into cash.

Leverage did not truly ease in FY2025. Long-term debt fell by about 14.2%, yet debt-to-equity still moved up to 0.7x; equity had shrunk by roughly 19.5%, so the capital cushion weakened faster than borrowings were retired.

From FY2023 to FY2025, shares outstanding rose about 12.8% while total equity fell about 19.9%. With annual dividends still above $299M, each share was backed by a smaller slice of book capital, which helps explain why per-share economics can feel tighter even when cash payouts continue.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

Prospect Capital does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial
3/7

Prospect Capital passes 3 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Mixed
N/A

Prospect Capital reported a net loss of $490.5M while generating $523.2M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$12.3M
YoY-55.4%

Prospect Capital generated $12.3M in revenue in fiscal year 2025. This represents a decrease of 55.4% from the prior year.

Net Income
-$490.5M
YoY-309.5%

Prospect Capital reported -$490.5M in net income in fiscal year 2025. This represents a decrease of 309.5% from the prior year.

EPS (Diluted)
-$1.35

Prospect Capital earned -$1.35 per diluted share (EPS) in fiscal year 2025.

EBITDA

Not reported for fiscal year 2025.

Cash & Balance Sheet

Cash & Debt
$50.8M
YoY-40.9%

Prospect Capital held $50.8M in cash against $2.1B in long-term debt as of fiscal year 2025.

Shares Outstanding
456M

Prospect Capital had 456M shares outstanding in fiscal year 2025.

Free Cash Flow

Not reported for fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Return on Equity
-16.4%
YoY-22.7pp

Prospect Capital's ROE was -16.4% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 22.7 percentage points from the prior year.

Gross Margin

Not reported for fiscal year 2025.

Operating Margin

Not reported for fiscal year 2025.

Net Margin

Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

None of these metrics is reported for fiscal year 2025.

PSEC Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

PSEC annual income statement
MetricTTMFY25FY24FY23FY22FY21FY20
Revenue$10.7M$12.3M-55.4%$27.7M+52.6%$18.1M-58.5%$43.7M+26.0%$34.7MN/A
Interest Expense$132.4M$148.3M-7.5%$160.2M+8.1%$148.2M+26.2%$117.4M-10.1%$130.6MN/A
Net Income-$58.3M-$490.5M-309.5%$234.1M+365.9%-$88.0M-112.0%$735.3M+71.8%$428.1M+642.3%-$78.9M
EPS (Diluted)-$1.35$0.34-$0.43$1.34$2.50N/A

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, Income Tax.

TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

PSEC Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

PSEC annual balance sheet
MetricFY25FY24FY23FY22FY21FY20
Total Assets$6.8B-13.4%$7.9B-0.1%$7.9B+2.6%$7.7BN/AN/A
Cash & Equivalents$50.8M-40.9%$85.9M-10.2%$95.6M+170.5%$35.4M-44.4%$63.6MN/A
Total Liabilities$3.8B-7.9%$4.1B+52.9%$2.7B-5.0%$2.9BN/AN/A
Long-Term Debt$2.1B-14.2%$2.4B-5.8%$2.6B-5.6%$2.7BN/AN/A
Total Equity$3.0B-19.5%$3.7B-0.6%$3.7B-9.4%$4.1B+4.4%$3.9BN/A
Retained Earnings-$1.3B-387.4%$436.3M+223.6%-$352.9M-616.3%$68.4M+132.5%-$210.6MN/A

Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Goodwill, Current Liabilities.

PSEC Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

PSEC annual cash flow statement
MetricTTMFY25FY24FY23FY22FY21FY20
Operating Cash Flow$552.6M$523.2M+86.9%$280.0M+226.8%-$220.8M+72.2%-$795.3M-2664.0%$31.0MN/A
Financing Cash Flow-$572.6M-$558.3M-92.7%-$289.8M-203.1%$281.1M-63.4%$767.1M+6508.5%-$12.0MN/A
Dividends Paid$327.1M$332.4M-7.7%$360.3M+20.4%$299.1M+10.7%$270.3M+38.2%$195.6MN/A

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Investing Cash Flow, Share Buybacks.

TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

PSEC Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

PSEC annual financial ratios
MetricFY25FY24FY23FY22FY21FY20
Net Margin-3972.3%846.2%-485.6%1683.4%1234.6%N/A
Return on Equity-16.4%-22.7pp6.3%+8.7pp-2.4%-20.2pp17.8%+7.0pp10.8%N/A
Return on Assets-7.2%-10.2pp3.0%+4.1pp-1.1%-10.7pp9.6%N/AN/A
Debt-to-Equity0.700.0x0.660.0x0.690.0x0.66N/AN/A

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, FCF Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.

Similar Companies

Frequently Asked Questions

What is Prospect Capital's annual revenue?

Prospect Capital (PSEC) reported $12.3M in total revenue for fiscal year 2025. This represents a -55.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Prospect Capital's revenue growing?

Prospect Capital (PSEC) revenue declined by 55.4% year-over-year, from $27.7M to $12.3M in fiscal year 2025.

Is Prospect Capital profitable?

No, Prospect Capital (PSEC) reported a net income of -$490.5M in fiscal year 2025.

Prospect Capital (PSEC) reported diluted earnings per share of -$1.35 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

As of fiscal year 2025, Prospect Capital (PSEC) had $50.8M in cash and equivalents against $2.1B in long-term debt.

Prospect Capital (PSEC) has a return on equity of -16.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Prospect Capital (PSEC) generated $523.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Prospect Capital (PSEC) had $6.8B in total assets as of fiscal year 2025, including both current and long-term assets.

Prospect Capital (PSEC) had 456M shares outstanding as of fiscal year 2025.

Prospect Capital (PSEC) had a debt-to-equity ratio of 0.70 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Prospect Capital (PSEC) had a return on assets of -7.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Prospect Capital (PSEC) has a Piotroski F-Score of 3 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Prospect Capital (PSEC) reported a net loss of $490.5M while generating $523.2M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top